StockData

Endonovo Therapeutics, Inc. (ENDV) income statement

ENDVOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2023, quý kết thúc ngày Sep 30, 2023Last filing: 10-Q/A on Dec 29, 2023
$0.00+0.00 (0.00%)

Close on Oct 19, 2026Market cap $135.08KP/E –Yield –

Endonovo Therapeutics, Inc. income statement

Ratios

Latest available, balances at Sep 30, 2023

Profitability, TTM

Gross margin
96.2%
Operating margin
-1023.2%
Net margin
-1722.2%
Return on equity, FY2022
77.1%

Financial strength

Current ratio
0.00
Debt to equity
–
Debt to assets
–
Cash to current liabilities
0.0%

Valuation

P/E ratio
–
Price to sales
0.53
Price to book
–
Dividend yield
–

See a number that looks wrong?